Survival Trends and Prognostic Modeling in ALK‐Positive Anaplastic Large Cell Lymphoma: A Population‐Based Study in the Brentuximab Vedotin Era
ABSTRACT Background ALK‐positive anaplastic large cell lymphoma (ALK+ ALCL) is a rare subtype of peripheral T‐cell lymphoma with traditionally favorable prognosis. The introduction of brentuximab vedotin (BV) has significantly impacted treatment outcomes, but the long‐term survival trends and predic...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wiley
2026-03-01
|
| Col·lecció: | Cancer Medicine |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1002/cam4.71695 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|